Z15.02
Genetic susceptibility to malignant neoplasm of ovary
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code Z15.02 refers to a genetic predisposition to malignant neoplasm of the ovary, indicating that an individual has inherited genetic factors that increase their risk of developing ovarian cancer. This classification helps healthcare providers identify patients who are at a higher genetic risk and may benefit from targeted screening and preventive measures. Understanding this code aids in recognizing the importance of genetic factors in cancer development and the need for personalized medical care tailored to genetic risk profiles.
Causes & Symptoms
Clinical Causes: Inherited gene mutations, such as BRCA1 and BRCA2 Family history of ovarian or related cancers Genetic syndromes associated with increased cancer risk, like Lynch syndrome Other rare genetic mutations linked to ovarian cancer susceptibility
Key Symptoms: No symptoms are typically present in the early stages Persistent bloating, pressure sensation in the abdomen Pelvic or abdominal pain Frequent urination or difficulty emptying the bladder Unexplained weight loss or gain Feeling full quickly after eating
Diagnostic & Treatment
Diagnosis Path: Diagnosis of genetic susceptibility involves a combination of genetic counseling and testing. Healthcare providers may recommend genetic testing to identify inherited mutations associated with increased ovarian cancer risk. Family history assessments are also crucial, along with medical imaging and examinations if symptoms are present. The goal is to determine the presence of genetic risk factors, which can guide surveillance and preventive strategies.
Treatment Protocols: While there is no treatment to alter genetic susceptibility itself, management strategies focus on risk reduction and early detection. Options include increased surveillance, lifestyle modifications, and preventive surgeries like risk-reducing salpingo-oophorectomy in high-risk individuals. Participation in genetic counseling can help patients understand their options and make informed decisions about their health. Ongoing research continues to improve preventive approaches and targeted therapies for those at increased genetic risk.
Clinical Advice & FAQs
Billing Guidance
Is Z15.02 a billable ICD-10 code?
Yes, Z15.02 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z15.02?
Clinical documentation must specify the nature of Genetic susceptibility to malignant neoplasm of ovary and any associated comorbidities for accurate reporting.
Cite this Clinical Reference